Valuation: Medistim ASA

Market Cap 5.84B 613M 549M 506M 460M 870M 57.43B 894M 6.06B 2.42B 30.77B 2.3B 2.25B 97.27B P/E 2026 *
31x
P/E 2027 * 26.4x
Enterprise Value 5.7B 599M 537M 495M 449M 851M 56.14B 874M 5.92B 2.36B 30.08B 2.25B 2.2B 95.08B EV / Sales 2026 *
6.86x
EV / Sales 2027 * 6.1x
Free-Float
69.57%
Yield 2026 *
3.21%
Yield 2027 * 3.37%
1 day-1.57%
1 week+2.28%
Current month+2.95%
1 month+11.74%
3 months+37.72%
6 months+38.94%
Current year+21.24%
1 week 295
Extreme 295
323
1 month 274
Extreme 274
323
Current year 186.5
Extreme 186.5
323
1 year 186.5
Extreme 186.5
323
3 years 130
Extreme 130
323
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2009
Director of Finance/CFO - 01/01/2001
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Chairman 78 01/01/2000
Director/Board Member 49 01/01/2014
Director/Board Member 56 01/04/2023
Date Insider Type Main position Quantity % Market Cap. Importance
04/03/25 Buy

Chairman

860,735 4.6939%
27/01/25 Buy

Chairman

45,000 0.2454%
09/01/25 Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
-1.57%+2.28%+29.75%+61.03% 620M
-0.40%+2.92%+24.70%+60.27% 267B
+0.45%+2.82%+12.04%+20.10% 165B
-2.32%+2.15%-21.87%+62.24% 160B
+0.83%+2.79%-55.69%-13.28% 63.81B
-0.67%+9.40%+23.86%+62.19% 60.21B
-0.51%-0.95%-0.97%-9.81% 53.82B
-1.15%+1.58%+21.78%+64.31% 50.8B
-0.28%+0.95%+3.50%+85.43% 49.61B
-0.21%+3.58%+26.50%+86.14% 46.83B
Average -0.45%+3.86%+6.36%+47.86% 92B
Weighted average by Cap. -0.44%+4.38%+5.96%+47.19%

Financials

2026 *2027 *
Net sales 831M 87.23M 78.23M 72.09M 65.47M 124M 8.18B 127M 863M 344M 4.38B 327M 320M 13.85B 938M 98.46M 88.3M 81.38M 73.9M 140M 9.23B 144M 974M 388M 4.95B 370M 362M 15.64B
Net income 189M 19.84M 17.79M 16.4M 14.89M 28.18M 1.86B 28.97M 196M 78.22M 997M 74.45M 72.87M 3.15B 221M 23.2M 20.8M 19.17M 17.41M 32.95M 2.17B 33.87M 230M 91.46M 1.17B 87.06M 85.21M 3.68B
Net Debt -132M -13.8M -12.38M -11.41M -10.36M -19.61M -1.29B -20.16M -137M -54.42M -693M -51.8M -50.7M -2.19B -118M -12.33M -11.06M -10.19M -9.26M -17.52M -1.16B -18.01M -122M -48.63M -620M -46.29M -45.31M -1.96B
Projected Income Statement - Annual - Medistim ASA
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
10/11/26 NOK 314.00 -1.57% 13,968
09/11/26 NOK 319.00 +4.25% 58,420
06/11/26 NOK 306.00 0.00% 20,838
05/11/26 NOK 306.00 +2.68% 16,035
04/11/26 NOK 298.00 -1.00% 14,306
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medistim ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
319.00NOK
Average target price
365.00NOK
Spread / Average Target
+14.42%
  1. Stock Market
  2. Stocks
  3. MEDI Stock